Einloggen
E-Mail
Passwort
Passwort anzeigen
Merken
Passwort vergessen?
Werden Sie kostenlos Mitglied
Registrieren
Registrieren
Mitglied werden
Kostenlos registrieren
Abonnent werden
Unser Angebot
Einstellungen
Einstellungen
Dynamische Kurse 
OFFON

MASIMO CORPORATION

(578074)
  Bericht
ÜbersichtKurseChartsNewsRatingsTermineUnternehmenFinanzenAnalystenschätzungenRevisionenDerivate 
ÜbersichtAlle NewsAndere SprachenPressemitteilungenOffizielle PublikationenBranchen-News
Nachrichten in anderen Sprachen über MASIMO CORPORATION
12.10.MASIMO : to Report Third Quarter 2021 Financial Results After Market Close on Tuesday, Oct..
04.10.MASIMO : and University Hospitals Partner to Combat Nurse Burnout
04.10.Masimo Corporation and University Hospitals Partner to Combat Nurse Burnout
28.09.MASIMO : Un nuevo estudio evalúa la viabilidad de utilizar la capnografía EMMA® en neonato..
27.09.MASIMO : Une nouvelle étude évalue la faisabilité de l'utilisation de la capnographie EMMA..
27.09.MASIMO : New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanic..
27.09.New Study Evaluates the Feasibility of Using Masimo EMMA® Capnography on Mechanically V..
22.09.MASIMO : CEO Joe Kiani Appointed to President's Council of Advisors on Science and Technol..
22.09.Masimo Corporation Announces Executive Changes
16.09.MASIMO : lance le rainbow® SuperSensor™ à usage individuel
15.09.MASIMO : lanza el sensor rainbow® SuperSensor™ para uso de un solo paciente
13.09.MASIMO : SuperSensor Technology Gets CE Mark in Europe
13.09.MASIMO : Launches Single-patient-use rainbow® SuperSensor™
13.09.Masimo Launches Single-Patient-Use Rainbow SuperSensor
08.09.MASIMO : to Present in Morgan Stanley 19th Annual Global Healthcare Conference
07.09.MASIMO : Un nuevo estudio investiga la capacidad de Masimo ORi™ de alertar pronto so..
06.09.MASIMO : Une nouvelle étude examine la capacité de l'indice ORi™ de Masimo à fournir..
06.09.MASIMO : New Study Investigates the Ability of Masimo ORi™ to Provide Early Warning ..
06.09.New Study Investigates the Ability of Masimo Ori™ to Provide Early Warning of Hypoxemia..
01.09.MASIMO : se asocia con Penington Institute para generar conciencia sobre el daño por sobre..
01.09.MASIMO : lance SafetyNet Alert™ en Europe de l'Ouest
01.09.MASIMO : Lanzamiento de Masimo SafetyNet Alert™ en Europa Occidental
31.08.MASIMO : s'associe avec le Penington Institute pour sensibiliser au préjudice lié aux over..
31.08.MASIMO : Partners with Penington Institute to Raise Awareness of Harm from Prescription Op..
30.08.MASIMO : SafetyNet Alert™ Launches in Western Europe
30.08.Masimo SafetyNet Alert™ Launches in Western Europe
28.08.MASIMO : Une publication de la Society for the Advancement of Patient Blood Management (SA..
27.08.MASIMO : Una Publicación de la Society for Advancement of Patient Blood Management (SABM) ..
26.08.MASIMO : Society for the Advancement of Patient Blood Management (SABM) Publication Recomm..
24.08.MASIMO : Un nuevo estudio evalúa el uso de Masimo PVi® para monitorear el estado del volum..
24.08.MASIMO : Une nouvelle étude évalue l'utilisation du PVi® de Masimo dans le cadre de la sur..
23.08.MASIMO : Says Study Shows PVi Provides 'Useful Information' for Monitoring Volume Status i..
23.08.MASIMO : New Study Evaluates the Use of Masimo PVi® to Monitor Volume Status in Spontaneou..
16.08.MASIMO : New Study Evaluates the Use of Masimo Bridge® As an Alternative to Opioids
27.07.MASIMO : Management's Discussion and Analysis of Financial Condition and Results of Operat..
27.07.Tranche Update on Masimo Corporation's Equity Buyback Plan announced on August 1, 2018.
27.07.MASIMO : Reports Second Quarter 2021 Financial Results (Form 8-K)
27.07.MASIMO : Earnings, Sales Increase in Q2; Lifts FY21 Revenue, EPS Guidance
27.07.MASIMO CORP : Results of Operations and Financial Condition (form 8-K)
27.07.MASIMO : Q2 Earnings Snapshot
27.07.MASIMO : Q2 2021 Supplemental Presentation to Earnings Press Release
27.07.MASIMO : FY2017 to Q2 2021 Supplemental Financial Information
27.07.GUIDANCE : (MASI) MASIMO Expects Fiscal Year 2021 EPS $3.85
27.07.MASIMO : Earnings Flash (MASI) MASIMO Posts Q2 EPS $0.94, vs. Street Est of $0.90
27.07.MASIMO : Reports Second Quarter 2021 Financial Results
27.07.Masimo Corporation Reports Earnings Results for the Second Quarter Ended July 3, 2021
27.07.Masimo Corporation Provides Earnings Guidance for the Full Year 2021
19.07.MASIMO : Introduces the MX-7™ rainbow SET® Technology Board for Original Equipment M..
19.07.Masimo Introduces the MX-7™ Rainbow Set® Technology Board for Original Equipment Manufa..
13.07.MASIMO : to Report Second Quarter 2021 Financial Results after Market Close on Tuesday, Ju..
07.07.MASIMO : Un Nuevo Estudio Evalúa la Capacidad de Monitoreo de la Función Cerebral de SedLi..
07.07.MASIMO : Une nouvelle étude évalue la capacité du système de surveillance de la fonction c..
06.07.MASIMO : New Study Evaluates the Ability of Masimo SedLine® Brain Function Monitoring to P..
06.07.Masimo Announces New Study Evaluates the Ability of Masimo Sedline® Brain Function Moni..
30.06.Masimo Corporation's Equity Buyback announced on August 1, 2018, has expired with 1,277..
25.06.MASIMO CORPORATION(NASDAQGS : MASI) added to Russell Midcap Value Index
25.06.MASIMO CORPORATION(NASDAQGS : MASI) added to Russell 2500 Growth Index
25.06.MASIMO CORPORATION(NASDAQGS : MASI) added to Russell 3000 Value Index
25.06.MASIMO CORPORATION(NASDAQGS : MASI) added to Russell 1000 Value Index
25.06.MASIMO CORPORATION(NASDAQGS : MASI) added to Russell 2500 Value Index
25.06.MASIMO CORPORATION(NASDAQGS : MASI) added to Russell Small Cap Comp Value Index
25.06.MASIMO CORPORATION(NASDAQGS : MASI) added to Russell 1000 Value-Defensive Index
25.06.MASIMO CORPORATION(NASDAQGS : MASI) added to Russell 3000E Value Index
25.06.MASIMO CORPORATION(NASDAQGS : MASI) added to Russell 2500 Index
21.06.MASIMO : Receives 510(K) Clearance From FDA for Radius T Thermometer
21.06.MASIMO : Announces FDA 510(k) Clearance of Radius Tº™ for Prescription and Over-the-..
21.06.Masimo Announces FDA 510(K) Clearance of Radius Tº for Prescription and Over-The-Counte..
15.06.MASIMO : Une nouvelle étude examine l'impact du titrage d'oxygène guidé par ORi sur la mor..
15.06.MASIMO : Un nuevo estudio investiga el impacto del ajuste de oxígeno basado en ORi en proc..
14.06.MASIMO : New Study Investigates the Impact of ORi™-Guided Oxygen Titration on Hypero..
14.06.MASIMO : New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-M..
14.06.Masimo Corporation Announces New Study Investigates the Impact of ORi-Guided Oxygen Tit..
02.06.INSIDER TRENDS : Insider at Masimo Reports Option Conversion in Mist of 90-Day Buying Tren..
01.06.INSIDER TRENDS : Insider at Masimo Converts Options in Mist of 90-Day Buying Trend
01.06.INSIDER TRENDS : Masimo Insider Exercises Options Extending 90-Day Buying Trend
1  2  3  4  5  6  7  8  9  10Weiter
Anstehende Termine für MASIMO CORPORATION